Johnson & Johnson sales
This article was originally published in The Tan Sheet
Executive Summary
J&J's acquisition of Merck's stake in the European nonprescription joint venture drove 17% jump in second quarter operational growth for the firm's McNeil OTC and nutritional franchise compared with the year-ago quarter, the firm announces in a July 13 analysts call. The new McNeil Europe subsidiary will handle the launch of Zocor Heart-Pro nonprescription statin in the UK (1"The Tan Sheet" April 26, 2004, p. 6). International consumer product sales grew 14.1%, or 9%, excluding the impact of currency exchange, to $1.01 bil., compared with the second quarter of 2003. U.S. consumer sales grew 6% to $987 mil., with worldwide consumer sales totaling $2 bil., up 7.5 % excluding currency exchange...